Additionally, patients in the adverse outcome group appeared to be older(75 vs. 72 years), accompanied by comorbidities(hypertension:70% vs. 67%; coronary heart disease: 70% vs. 56%) and higher levels of CRP(67.29[20.84,127.00] mg/L vs. 41.72 [7.51,95.99]mg/L), D-dimmer(1.76 [0.96,2.85] μg/mL vs. 0.97[0.56,1.81]μg/mL) on admission but there was no significant difference between the two groups. This evidence concerns the gene CRP and Hypertension.